Bone C Fos 35mg Tablet
By Bone C Fos
Rx
4 Tablet in a Strip

Composition
Risedronate(35mg)

Manufacturer - Molekule India Pvt Ltd
CRIMPAGE CORPORATION, 3RD FLOOR, PLOT NO. 57, STREET NO. 17, MIDC, MAROL, ANDHERI (EAST), MUMBAI MH 400093 IN , - , .

Expires on or after
September, 2025

liver
Bone C Fos 35mg Tablet is considered safe for use in individuals with liver disease. Current evidence indicates that adjusting the dosage of Bone C Fos 35mg Tablet may not be necessary for these patients. It is advisable to consult with your doctor regarding the use of this medication in case of any liver-related concerns.

kidney
Bone C Fos 35mg Tablet should be used carefully in patients with kidney disease. Consult your doctor for potential dose adjustment. Avoid in severe kidney disease. No dose change needed in mild to moderate cases.

alcohol
Caution is advised when consuming alcohol with Bone C Fos 35mg Tablet. It is important to consult your doctor.

driving
Bone C Fos 35mg Tablet typically does not impact driving ability.

pregnancy
Caution is advised when using Bone C Fos 35mg Tablet during pregnancy. Limited human studies show potential risks, and animal studies suggest harm to the developing baby. Consult your doctor to weigh the benefits and risks before using this medication.

breastfeeding
Bone C Fos 35mg Tablet is considered safe during breastfeeding based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Bisphosphonate Derivative |
Therapeutic Class | PAIN ANALGESICS |
Action Class | Bone resorption inhibitor -Bisphosphonates |
₹142.86
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024